Microsoft word - living with lupus.rtf

Acetylation/acetyltransferase, 153–154, 154 ACL (anti-cardiolipin), 95, 135–136, 174 ACR. See American College of Rheumatology (ACR) . See also Osteonecrosis; Osteoporosis American Academy of Orthpaedic Surgeons (AAOS), diagnostic criteria, 20–21, 22–30, 200 ANA (antinuclear antibodies), 29–30, 151 Angio-tensin-converting-enzyme (ACE), 140 Centers for Disease Control and Prevention (CDC), 2, Anti-inflammatory drugs. See Corticosteroids anti-cardiolipin (ACL), 95, 135–136, 174 psychological/emotional concerns, 207–209 anti-phospholipids (APLs), 32–33, 135–137 APLs (Anti-phospholids), 32–33, 135–137 Arthritis, 24–25, 32, 180–181, 199–200 Connie's story, 10–13, 65–66, 69, 75, 185, 186, 188 Arthritis Foundation, 61, 191, 221–222 Counseling, phsycological/psychiatric, 208–209 Eileen's story, 12–13, 32, 71–72, 86–88, 98, 185–186, Elizabeth's story, 13–14, 27, 71, 167, 185, 186–187, Emotional health, 69–70, 191–195, 207–209 Erythrocyte sedimentation rate (ESR), 31 additional signs, symptoms, tests, 30–34 antinuclear antibodies (ANA), 29–30, 151 Extractable nuclear antigens (ENA), 31–32 Diagnostic and Therapeutic Criteria Committee, 20 Eye, dry. See Sjögren's syndrome Dietary supplements. See Supplements Discoid lupus erythematosus (DLE). See Discoid Food and Drug Administration (FDA), 140, 156, 159– . See also Congenital heart block; Libman-Sacks Drug-induced lupus. See Lupus-like syndrome (LLS) Drug-related lupus. See Lupus-like syndrome (LLS) silicone gel implant, precautions for, 161–163 HLA (histocompatibility) typing, 40–41, 103–105, 153 HTLV (human T-cell lymphotropic virus), 48 Human immunodeficiency virus. See AIDS Hydralazine/Hydrazine, 152, 154, 155, 166, 169 Hydroxychloroquine, 75–76, 78, 143–144, 201 Mouth, dry. See Sjögren's syndrome Immune thrombocytopenia (ITP), 26, 94–95, 136 Immunosuppressants, 80–82, 201, 202, 204 International Human Renal Transplant Registry, 103 Nancy's story, 16–17, 69, 71, 75, 90, 187, 189 ITP (immune thrombocytopenia), 26, 94–95, 136 National Institutes of Health (NIH), 50, 81–82, 111– Jan's story, 14–15, 24–25, 56–57, 69, 91, 167, 187, Nephritis, nephrosis, nephrotic syndrome, 100 Joint disease. See Arthritis; Osteonecrosis Nonsteroidal anti-inflammatory drugs. See NSAIDs Kidney disease, 26, 32, 90–91, 99–105 Light sensitivity. See Photosensitivity alternative/additional medicine, 116–118 Lisa's story, 15–16, 69, 76, 97, 98, 171, 221 Lupus Foundation of America (LFA), 61, 222 Patient/doctor relationship. See Doctor/patient Raynaud's syndrome. See Raynaud's phenomenon Renal disease, 26, 32, 90–91, 99–105 Photosensitivity, 23–24, 54–55, 170–173, 201–202 Physician. See Doctor/patient relationship Seizures. See Neurologic disorder Silicone gel implants. See Breast implants Sjögren's syndrome, 32, 49, 156–157, 175–177 Premature childbirth, 112, 133–134, 145–146 President's Council on Physical Fitness, 120–131 SSPE (subacute sclerosing panencephalitis), 51–52 Raynaud's disease. See Raynaud's phenomenon T T-cells, 48, 49–50 Tai chi, 193 Tamoxifen, 183, 215–216 Tartrazine, 166, 173 Teens. See Children and teens Tendon rupture, 98 Thorazine, 152 Throat sores, 24 Thrombocytopenia, 26, 94–95, 136 Thrombophlebitis, 12 Thyrocalcitonin, 116 Tolmetin, 80 Total lymphoid irradiation (TLI), 213–214 Toxemia of pregnancy, 141–142 Treatment plan, 63–65 . See also Corticosteroids; Drug therapy Triamcinolone, 88, 91 Tripterygium wilfordii, 217 Tubal ligation, 148 Twins, 39–40, 198–199 U Ulcers, 24, 180 Uniform Anatomical Gift Act, 104 United Network for Organ Sharing, 103 Uremia, 100 V Vaccinations. See Immunizations Varicella. See Chicken pox Varicella-zoster virus (VZV), 46, 99 Vasospasm, 82 Verrucous endocarditis, 174–175 Virus, 45–54, 98–99 Vitamin A, 115 Vitamin D, 114 VZIG (varicella-zoster immune globulin), 205–206 W Weight, 92, 199 Z Zantac, 79 Zinc, 115 Zocor, 153 Zorivax, 99, 206

Source: http://lakeshoreindexing.com/yahoo_site_admin/assets/docs/Living_with_Lupus.19120016.pdf

Estatutos

Estatutos de Befesa Medio Ambiente, S.A. Artículo 3.- Traslado de domicilio. Acuerdo de la Junta General Ordinaria de Accionistas de 17 de abrilArtículo 5- Texto vigente aprobado según acuerdo de la Junta General Ordinaria del 21 de junio deArtículos 6, 8, 11, 12, 13, 14, 15 18, 23 y 24 Texto vigente según Decisión del Accionista Único deArtículo 17.- Texto vigente aprobado según

Etat_résulats_définitifs

CHAMPIONNAT NATIONAL Show affilié à l'European Arab Horse Show Commission sous le n° 256-2013/MO RESULTATS DU SHOW CHAMPIONNAT NATIONAL Classe 1 JURY CLASSES Poulains de 1 an Dr MAREK TRELA Dr TON HULSHOF Dr NASHAAT HEGAZY Dr ABDERAZZAK HMIDANI Dr ABDELOUAHED MAAGOUL Dr MOHAMED OUSSIDHOUM Nom Cheval Date naissance Nom et prènom CHAMPIO

Copyright © 2010-2018 Pharmacy Drugs Pdf